SCHEMBL774310

SCHEMBL774310

CCOC(=O)c1cnn(C2CCCCC2)c1C1CCCO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
S1PR1 P21453 2/20 0.45
PDE4B Q07343 4/20 0.41
ALDH1A1 P00352 4/20 0.41
TSHR P16473 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPT P10636 1/20 0.41
NPC1 O15118 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
OPRK1 P41145 1/20 0.39
MAPK1 P28482 1/20 0.39
PKM P14618 1/20 0.38
KDM4E B2RXH2 1/20 0.38
P2RY12 Q9H244 1/20 0.38
KMT2A Q03164 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL773519 0.83 LMNA (0.47) LMNAS1PR1PDE4BALDH1A1TSHR
SCHEMBL13848928 0.80 LMNA (0.55) LMNAPDE4BALDH1A1TSHRNPSR1
SCHEMBL574443 0.78 LMNA (0.53) LMNAPDE4BALDH1A1TSHRNPSR1
SCHEMBL1407107 0.77 LMNA (0.66) LMNAPDE4BALDH1A1TSHRNPSR1
SCHEMBL1406968 0.77 LMNA (0.53) LMNAPDE4BALDH1A1TSHRNPSR1
SCHEMBL13887607 0.77 LMNA (0.53) LMNAPDE4BALDH1A1TSHRNPSR1
SCHEMBL5638500 0.77 LMNA (0.53) LMNAPDE4BALDH1A1TSHRNPSR1
SCHEMBL30984286 0.77 LMNA (0.52) LMNAPDE4BALDH1A1TSHRNPSR1
SCHEMBL25371570 0.76 KDM4E (0.40) LMNAPDE4BALDH1A1NPSR1NPC1
SCHEMBL1406792 0.76 LMNA (0.51) LMNAPDE4BALDH1A1TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440554-B1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2016-10-05 EP disclosed
EP-2440554-B1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2016-10-05 EP disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-8802663-B2 Pyrazole oxadiazole derivatives as S1P1 agonists MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO SA (CH) 2012-03-22 US disclosed
WO-2010142628-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS MERCK SERONO S.A. (CH) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071460-A1 PYRAZOLE OXADIAZOLE DERIVATIVES AS S1P1 AGONISTS S1PR1, S1PR3, S1PR2 LMNA 4315/4885S1PR1 1/4885PDE4B 218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.